Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES CORESEC SYSTEMS HOLDING AB
Mandate

VINGE ADVISES CORESEC SYSTEMS HOLDING AB

May 05, 2015

Vinge has advised Coresec Systems Holding AB, which is majority-owned by Perusa Partners Fund 2 L.P., in connection with its acquisition of the Swedish IT security company ISecure Sweden AB.

Vinge’s team consisted of responsible counsel Ulrich Ziche together with associates Johan Steen, Mårten Svensson and Andrea Jägerstad (M&A), partner Karin Grauers (commercial agreements, etc.), associates Åsa Gotthardsson and Tomas Forsgren (employment), Helena Höök and Johan Wahlbom (public procurement and competition) as well as Mathilda Gustafsson (real estate). Partner Mikael Ståhl and associate Lynn Adewald provided financing advice.

For further information, see Coresec’s press release: http://www.coresec.se/news/

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026